These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6722646)

  • 21. Plasma coagulation factor abnormalities in dogs with naturally occurring hepatic disease.
    Badylak SF; Dodds WJ; Van Vleet JF
    Am J Vet Res; 1983 Dec; 44(12):2336-40. PubMed ID: 6660623
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The activated partial thromboplastin time-clot waveform analysis in hemophilia: Does it help in differentiation?
    Mannan KA; Kumar N; Ahluwalia J; Hans C; Kler A; Prakash G; Jain R
    Int J Lab Hematol; 2023 Apr; 45(2):241-249. PubMed ID: 36495061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determination of normal values using an automated coagulation timer for activated coagulation time and its application in dogs with hemophilia.
    Gerber B; Taboada J; Lothrop CD; Busato A; Hosgood G; Goodman SA; Gaschen FP
    J Vet Intern Med; 1999; 13(5):433-6. PubMed ID: 10499726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The monitoring of heparin administration by screening tests in experimental dogs.
    Mischke R; Jacobs C
    Res Vet Sci; 2001 Apr; 70(2):101-8. PubMed ID: 11356088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the activated partial thromboplastin time assay for clinical monitoring of PEGylated recombinant factor VIII (BAY 94-9027) for haemophilia A.
    Gu JM; Ramsey P; Evans V; Tang L; Apeler H; Leong L; Murphy JE; Laux V; Myles T
    Haemophilia; 2014 Jul; 20(4):593-600. PubMed ID: 24471985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Colloids decrease clot propagation and strength: role of factor XIII-fibrin polymer and thrombin-fibrinogen interactions.
    Nielsen VG
    Acta Anaesthesiol Scand; 2005 Sep; 49(8):1163-71. PubMed ID: 16095459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Agreement of point-of-care prothrombin and activated partial thromboplastin time in dogs with a reference laboratory.
    Yang W; Hosgood G; Luobikis K; Paul A
    Aust Vet J; 2018 Oct; 96(10):379-384. PubMed ID: 30255579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of a point-of-care coagulation analyzer (Abaxis VSPro) for identification of coagulopathies in dogs.
    Dixon-Jimenez AC; Brainard BM; Cathcart CJ; Koenig A
    J Vet Emerg Crit Care (San Antonio); 2013; 23(4):402-7. PubMed ID: 23796019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kaolin-correctable prolongation of the activated partial thromboplastin time.
    Briselli MF; Ellman L
    Am J Clin Pathol; 1980 Nov; 74(5):677-80. PubMed ID: 7446472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Standardization of coagulation tests.
    Opartkiattikul N
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():79-85. PubMed ID: 10926265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Novel Assessment of Factor VIII Activity by Template Matching Utilizing Weighted Average Parameters from Comprehensive Clot Waveform Analysis.
    Shimonishi N; Ogiwara K; Oda Y; Kawabe T; Okazaki S; Shima M; Nogami K
    Thromb Haemost; 2021 Feb; 121(2):164-173. PubMed ID: 32828071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparison of factor VIII:C and factor IX sensitivity of different commercial APTT reagents for canine plasma].
    Mischke R
    Berl Munch Tierarztl Wochenschr; 1999; 112(10-11):394-9. PubMed ID: 10598358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Verification of the guidelines for lupus anticoagulant detection: usefulness of index for circulating anticoagulant in APTT mixing test.
    Kumano O; Ieko M; Naito S; Yoshida M; Takahashi N; Suzuki T; Aoki T
    Thromb Res; 2014 Aug; 134(2):503-9. PubMed ID: 24935674
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monitoring direct thrombin inhibitors with a plasma diluted thrombin time.
    Love JE; Ferrell C; Chandler WL
    Thromb Haemost; 2007 Jul; 98(1):234-42. PubMed ID: 17598018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activated partial thromboplastin time.
    Ignjatovic V
    Methods Mol Biol; 2013; 992():111-20. PubMed ID: 23546708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The First-Derivative Curve of the Coagulation Waveform Reveals the Cause of aPTT Prolongation.
    Shimomura D; Matsumoto T; Sugimoto K; Takata T; Kouno A; Shimada M; Matsuo S; Kamioka M
    Clin Appl Thromb Hemost; 2020; 26():1076029620978810. PubMed ID: 33372824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of modified functional assays for activated protein C resistance in patients with basally prolonged aPTT.
    Montaruli B; Schinco P; Pannocchia A; Giorgianni A; Borchiellini A; Tamponi G; Pileri A
    Thromb Haemost; 1997 Sep; 78(3):1042-8. PubMed ID: 9308751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clearance of cryoprecipitated factor VIII in canine hemophilia A.
    Aufderheide WM; Skinner SF; Kaneko JJ
    Am J Vet Res; 1975 Apr; 36(4 Pt.1):367-70. PubMed ID: 1124873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activated partial thromboplastin time of owl monkey (Aotus trivirgatus) plasma.
    Mrema JE; Johnson GS; Kelley ST; Green TJ
    Lab Anim Sci; 1984 Jun; 34(3):295-8. PubMed ID: 6748609
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Properties of optical data from activated partial thromboplastin time and prothrombin time assays.
    Braun PJ; Givens TB; Stead AG; Beck LR; Gooch SA; Swan RJ; Fischer TJ
    Thromb Haemost; 1997 Sep; 78(3):1079-87. PubMed ID: 9308757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.